KEGG   DRUG: Pegapamodutide
Entry
D10970                      Drug                                   
Name
Pegapamodutide (USAN/INN)
Structure
Class
Antidiabetic agent
 DG02044  Hypoglycemic agent
  DG01493  GLP-1 receptor agonist
 DG03355  Oxyntomodulin analog
Efficacy
Antidiabetic, Glucagon-like peptide 1 (GLP-1) receptor agonist
  Type
Modified peptide
Comment
Oxyntomodulin analog [CPD:C18197] [HSA:2641] [KO:K05259]
Treatment of diabetes and obesity
Target
GLP1R [HSA:2740] [KO:K04581]
  Pathway
hsa04080  Neuroactive ligand-receptor interaction
hsa04911  Insulin secretion
Interaction
Brite
Drug groups [BR:br08330]
 Antidiabetic agent
  DG02044  Hypoglycemic agent
   DG01493  GLP-1 receptor agonist
    D10970  Pegapamodutide
  DG03355  Oxyntomodulin analog
   D10970  Pegapamodutide
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Secretin receptor family
   Glucagon
    GLP1R
     D10970  Pegapamodutide (USAN/INN)
Other DBs
CAS: 1492924-65-8
PubChem: 342581818
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system